[go: up one dir, main page]

Morsi, 2011 - Google Patents

Routine use of mini-pool nucleic acid testing (MP-NAT) multiplex assay for sero-negative blood donors

Morsi, 2011

View PDF
Document ID
11451309673994585979
Author
Morsi H
Publication year
Publication venue
J Egypt Soc Haematol Res

External Links

Snippet

ABSTRACT Background: Until December 2010, HBV-DNA NAT assay was not required by the FDA or recommended by the AABB. The FDA approved automated multiple assays that detect HIV-RNA, HCV-RNA, and HBV-DNA in one reaction chamber. These systems are …
Continue reading at eshr.edu.eg (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—AIDS or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Similar Documents

Publication Publication Date Title
Fotedar et al. Laboratory diagnostic techniques for Entamoeba species
Agarwal et al. Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India
US20030143530A1 (en) Method for the detection of influenza a/b viruses
La’ulu et al. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays
Burnett et al. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women
Pogany et al. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients
Morsi Routine use of mini-pool nucleic acid testing (MP-NAT) multiplex assay for sero-negative blood donors
Coulepis et al. Evidence that the genome of hepatitis A virus consists of single-stranded RNA
CN105659092B (en) The method for measuring cell free viral particle in dry blood cake
Simani et al. Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic
Uzun et al. Evaluation of hepatitis delta virus (HDV) infection in blood donors in western Turkey
Shrivastava et al. Nucleic acid amplification testing (NAT): an innovative diagnostic approach for enhancing blood safety
Chakravarti et al. Improved Detection of Dengue Virus Serotypes from Serum Samples-Evaluation of Single-Tube Multiplex RT-PCR with Cell Culture.
Singh et al. Prevalence of hepatitis E and hepatitis B dual infection in North India (Delhi)
Tang et al. Testing for SARS-CoV-2 (COVID-19): A General Review.
Marais et al. HIV‐1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV‐16 antibodies in female sex workers
CN105463131A (en) Human bocavirus LAMP (loop-mediated isothermal amplification) detection kit
Mangwana et al. Significance of nucleic acid testing in window period donations: Revisiting transfusion safety in high prevalence-low resource settings
Gogoi et al. Suspected SARS-Cov-2 reinfections in health care workers from Assam, India: Are they true reinfections
Igetei et al. Occult hepatitis B virus infection in Nigerian patients on haemodialysis
Zaki et al. Prevalence of hepatitis E virus among hemodialysis patients: one Egyptian Center Study
CN104711370A (en) Ebola virus typing fluorescence PCR detection kit
Chandra et al. Nucleic acid testing in blood donors of northern India: a single centre experience
Cunningham et al. Incremental detection of HIV infections by the HIV antigen/antibody combination assays: an Australian experience
Chaithanya et al. Evaluation of nucleic acid testing [NAT] of blood donors